AULIS CAPITAL GP I, LP
AULIS CAPITAL GP I, LP is a Seed and Series C+ fund in Global and asia investing in Healthcare, medical-devices and diagnostics.
- Stages
- Seed, Series C+
- Sectors
- Healthcare, medical-devices, diagnostics
- Invests in
- Global, asia
- Actively investing
- Yes
- Founded
- 2025
Check size not disclosed
Thesis
Aulis Capital is a venture capital firm established in 2025, focusing on early and growth-stage companies in the healthcare sector, particularly biotechs and health techs. Their mission is to improve patient care and advance medical technology by identifying and supporting transformative opportunities. Aulis Capital also facilitates strategic partnerships, connecting global companies with engineering and clinical development strengths, especially in Asia, and recognizes China's role in the biopharma industry. While specific fund sizes and AUM are not disclosed, Aulis Capital Fund I is an open venture capital fund. The firm has a dual operational presence in Hong Kong and Palo Alto, California.
Common questions
Does AULIS CAPITAL GP I, LP invest at the Seed stage?
Yes. AULIS CAPITAL GP I, LP lists Seed and Series C+ among the stages it invests in.
Where does AULIS CAPITAL GP I, LP invest?
AULIS CAPITAL GP I, LP invests in Global and asia.